The American Medical Association on Oct. 6 added Current Procedural Terminology codes for the pediatric COVID-19 vaccine candidate and administration of the vaccine.
The provisional codes will become effective if and when the FDA grants emergency use authorization or full approval to Pfizer's COVID-19 vaccine in children ages 5 to 11.
The AMA said it published the code now to ensure providers are prepared in advance of the FDA decision.
"The AMA supports the goal of extending COVID-19 immunization protection to a broader age range of children," said AMA President Gerald Harmon, MD.
The AMA added the following codes:
- 91307, the Pfizer vaccine product code for pediatric patients
- 0071A, the vaccine administration code for the first dose for pediatric patients
- 0072A, the vaccine administration code for the second dose for pediatric patients